The Bone Health Debate: Unpacking the Complex Relationship Between GLP-1 Agonists and Skeletal Integrity
Nana Wu
For millions of Americans navigating the complexities of obesity and type 2 diabetes, the rise of GLP-1 receptor agonists—a class of drugs including Ozempic, Wegovy, and Zepbound—has signaled a seismic…
